Walvax Biotechnology Stock Hits Day Low of CNY 11.08 Amid Price Pressure

Walvax Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 3.21% as it reached an intraday low of CNY 11.08. This performance contrasts with the China Shanghai Composite, which saw a modest decrease of 0.16% on the same day. Over the past week, Walvax's stock has fallen by 6.46%, and its monthly performance reflects a significant drop of 30.31%. Despite these short-term challenges, the company has shown resilience over the past year, achieving a return of 5.39%, although this is below the Shanghai Composite's 17.19% gain. Long-term metrics indicate a more complex picture, with a substantial decline of 58.95% over three years and an even steeper drop of 82.52% over five years. Financially, Walvax has reported a remarkable increase in net profit of 4082.41% in its latest results, alongside positive outcomes in the last two quarters. The company maintains a market capitalization of CNY 17,496 million and a price-to-earnings ratio of 69.00, reflecting its current valuation dynamics within the pharmaceuticals and biotechnology sector.